Application of Gene Therapy for Treatment of Atrial Fibrillation
DOI:
https://doi.org/10.47611/jsrhs.v11i3.3543Keywords:
Atrial Fibrillation, Gene Therapy, Gene Regulation, Gene EditingAbstract
Atrial fibrillation is the most common arrhythmia globally and is associated with an increased risk for various other complications. Ablation, one of the most widely used treatments, is irreversible and can damage tissue surrounding the ablation line. Furthermore, many people with structural heart abnormalities or other conditions cannot be effectively treated. The complexity of atrial fibrillation and the uniqueness of each case make a universally effective treatment nearly impossible. The present paper describes the current treatments for atrial fibrillation and assesses the potential of gene therapy as a new clinical treatment. Further research into gene therapy could provide more targeted and effective treatments for atrial fibrillation and many other genetic conditions.
Downloads
References or Bibliography
American Heart Association. (2022, June 2). Atrial fibrillation medications. www.heart.org. Retrieved August 27, 2022, from https://www.heart.org/en/health-topics/atrial-fibrillation/treatment-and-prevention-of-atrial-fib
rillation/atrial-fibrillation-medications
Atrial Fibrillation (Afib): Causes, Symptoms and Treatment. (2022, May 1). Cleveland Clinic. Retrieved August 29, 2022, from https://my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib
Aynalem, M., Shiferaw, E., Gelaw, Y., & Enawgaw, B. (2021). Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia. Thrombosis journal, 19(1), 36. https://doi.org/10.1186/s12959-021-00287-6
Beinart, S. (2021, October 17). Synchronized electrical cardioversion. Overview, Indications, Contraindications. Retrieved August 27, 2022, from https://emedicine.medscape.com/article/1834044-overview#:~:text=Cardioversion%20is%20contraindicated%20for%20any,conditions%2C%20and%20multifocal%20atrial%20tachycardia.
Bikou, O., Thomas, D., Trappe, K., Lugenbiel, P., Kelemen, K., Koch, M., Soucek, R., Voss, F., Becker, R., Katus, H. A., & Bauer, A. (2011). Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovascular research, 92(2), 218–225. https://doi.org/10.1093/cvr/cvr209
Borealis, S. (2021, May 9). Lipid nanoparticles: The Underrated Invention Behind the vaccine revolution. scienceborealis.ca Blog. Retrieved August 27, 2022, from https://blog.scienceborealis.ca/lipid-nanoparticles-the-underrated-invention-behind-the-vaccine-revolution/#:~:text=In%20the%201990s%2C%20University%20of,on%20pH%2Dsensitive%20lipid%20nanoparticles.
British Heart Foundation. (2021, February 11). Watch: What are beta blockers and what do they do in your body? BHF. Retrieved August 27, 2022, from https://www.bhf.org.uk/informationsupport/heart-matters-magazine/medical/drug-cabinet/beta-blockers
Cakulev, I., Efimov, I. R., & Waldo, A. L. (2009). Cardioversion: past, present, and future. Circulation, 120(16), 1623–1632. https://doi.org/10.1161/CIRCULATIONAHA.109.865535
Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009). Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circulation. Arrhythmia and electrophysiology, 2(4), 349–361. https://doi.org/10.1161/CIRCEP.108.824789
Carver, K., Negrete, D., Waterman, M. K., & Daddacha, W. (2021). Vectors in gene therapy: Benefit for Glioblastoma patients. New Targeting in the Reversal of Resistant Glioblastomas, 161–176. https://doi.org/10.1016/b978-0-12-822527-1.00011-3
Chen, Z. (2022, March 17). The do's and don'ts after pacemaker surgery. RB&HH Specialist Care. Retrieved August 27, 2022, from https://www.rbhh-specialistcare.co.uk/news/dos-donts-pacemaker-surgery
Dallas, M. E. (2020, August 10). When do doctors recommend cardiac ablation for atrial fibrillation? Healthgrades. Retrieved August 27, 2022, from https://www.healthgrades.com/right-care/atrial-fibrillation/when-do-doctors-recommend-cardiac-ablation-for-atrial-fibrillation
Dokken K, Fairley P. Sodium Channel Blocker Toxicity. [Updated 2022 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534844/
Farraha, M., Kumar, S., Chong, J., Cho, H., & Kizana, E. (2018). Gene Therapy Approaches to Biological Pacemakers. Journal of Cardiovascular Development and Disease, 5(4), 50. MDPI AG. Retrieved from http://dx.doi.org/10.3390/jcdd5040050
Flotte, T. R., & Carter, B. J. (1995). Adeno-associated virus vectors for gene therapy. Gene therapy, 2(6), 357–362.
Ghzally Y, Ahmed I, Gerasimon G. Catheter Ablation. [Updated 2022 Jul 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470203/
Grönberg, T., Nuotio, I., Nikkinen, M., Ylitalo, A., Vasankari, T., Hartikainen, J. E., & Airaksinen, K. E. (2013). Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(10), 1432–1435. https://doi.org/10.1093/europace/eut106
Hunter, J. E., Ramos, L., & Wolfe, J. H. (2017). Viral vectors in the CNS ☆. Reference Module in Neuroscience and Biobehavioral Psychology. https://doi.org/10.1016/b978-0-12-809324-5.02446-9
Illinois, U. of. (2018, September 26). Digoxin: Side effects, warning, uses, and more. Healthline. Retrieved August 27, 2022, from https://www.healthline.com/health/drugs/digoxin-oral-tablet#:~:text=For%20people%20with%20ventricular%20fibrillation,for%20an%20abnormal%20heart%20rhythm.
Jing, S., Hu, S., & Ma, S. (2020). Analysis of postoperative complications and risk factors in patients with permanent pacemaker implantation. Journal of thoracic disease, 12(10), 5980–5985. https://doi.org/10.21037/jtd-20-2913
Johns Hopkins Medicine. Atrial fibrillation ablation. (2022, May 17). Retrieved August 27, 2022, from https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/atrial-fibrillation-ablation
Kamba, T., & McDonald, D. M. (2007). Mechanisms of adverse effects of anti-VEGF therapy for cancer. British journal of cancer, 96(12), 1788–1795. https://doi.org/10.1038/sj.bjc.6603813
Kandi, V., & Vadakedath, S. (2015). Effect of DNA Methylation in Various Diseases and the Probable Protective Role of Nutrition: A Mini-Review. Cureus, 7(8), e309. https://doi.org/10.7759/cureus.309
Kim KH, Kerndt CC, Adnan G, et al. Nitroglycerin. [Updated 2021 Nov 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482382/
Klabunde, R. W. (2011). Sodium-channel blockers (class I antiarrhythmics). Image for Cardiovascular Pharmacology Concepts, Richard E Klabunde PhD. Retrieved August 27, 2022, from https://www.cvpharmacology.com/antiarrhy/sodium-blockers#:~:text=Disopyramide%20is%20contraindicated%20for%20patients,infarction%20or%20sustained%20ventricular%20arrhythmias
Kulkarni, J. A., Myhre, J. L., Chen, S., Tam, Y., Danescu, A., Richman, J. M., & Cullis, P. R. (2017). Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine : nanotechnology, biology, and medicine, 13(4), 1377–1387. https://doi.org/10.1016/j.nano.2016.12.014
Lippi, G., Sanchis-Gomar, F., & Cervellin, G. (2021). Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. International journal of stroke: official journal of the International Stroke Society, 16(2), 217–221. https://doi.org/10.1177/1747493019897870
Liu, Z., & Donahue, J. K. (2014). The Use of Gene Therapy for Ablation of Atrial Fibrillation. Arrhythmia & electrophysiology review, 3(3), 139–144. https://doi.org/10.15420/aer.2014.3.3.139
Mah, A., & Roberts, R. (2022, June 13). Full stack genome engineering. Synthego. Retrieved August 27, 2022, from https://www.synthego.com/blog/genome-editing-techniques#7-gene-editing-techniques-tools-to-change-the-genome
Marcin, A. (2019, June 14). What to know about long-term blood thinner use. Healthline. Retrieved August 27, 2022, from https://www.healthline.com/health/living-with-atrial-fibrillation/advancements/long-term-blood-thinner-use#side-effects
Mark, H. F. (2014). Encyclopedia of polymer science and technology, 15 volume set (Vol. 14, pp. 519-520). New York, NY, USA:: Wiley.
Mayo Foundation for Medical Education and Research. (2021, October 19). Atrial fibrillation. Mayo Clinic. Retrieved August 27, 2022, from https://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/symptoms-causes/syc-20350624#:~:text=Atrial%20fibrillation%20(A%2Dfib),and%20other%20heart%2Drelated%20complications.
Mitani, K., & Kubo, S. (2002). (PDF) adenovirus as an integrating vector - researchgate. Retrieved August 28, 2022, from https://www.researchgate.net/publication/11269719_Adenovirus_As_An_Integrating_Vector
Nayak, S., & Herzog, R. W. (2010). Progress and prospects: immune responses to viral vectors. Gene therapy, 17(3), 295–304. https://doi.org/10.1038/gt.2009.148
Ng, W. by D. (2022, August 26). A brief history of CRISPR-Cas9 genome-editing tools. Bitesize Bio. Retrieved August 27, 2022, from https://bitesizebio.com/47927/history-crispr/
Pacemaker (for the heart): Surgery, types & what it is. Cleveland Clinic. (n.d.). Retrieved August 27, 2022, from https://my.clevelandclinic.org/health/treatments/17360-permanent-pacemaker
Platonov, P. G., McNitt, S., Polonsky, B., Rosero, S. Z., & Zareba, W. (2019). Atrial fibrillation in long QT syndrome by genotype. Circulation: Arrhythmia and Electrophysiology, 12(10). https://doi.org/10.1161/circep.119.007213
Poole, J. E., Bahnson, T. D., Monahan, K. H., Johnson, G., Rostami, H., Silverstein, A. P., Al-Khalidi, H. R., Rosenberg, Y., Mark, D. B., Lee, K. L., Packer, D. L., Poole, J. E., Akoum, N., Aoukar, P., Birgersdotter-Green, U., Blatt, J., Cha, Y. M., Chung, M., Gleva, M., . . . Wilson, M. (2020). Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. Journal of the American College of Cardiology, 75(25), 3105–3118. https://doi.org/10.1016/j.jacc.2020.04.065
Pratt, A. J., & MacRae, I. J. (2009). The RNA-induced silencing complex: a versatile gene-silencing machine. The Journal of biological chemistry, 284(27), 17897–17901. https://doi.org/10.1074/jbc.R900012200
Redman, M., King, A., Watson, C., & King, D. (2016). What is CRISPR/Cas9?. Archives of disease in childhood. Education and practice edition, 101(4), 213–215. https://doi.org/10.1136/archdischild-2016-310459
Sadler J. E. (2003). Von Willebrand disease type 1: a diagnosis in search of a disease. Blood, 101(6), 2089–2093. https://doi.org/10.1182/blood-2002-09-2892
Sadovsky, R. (2003, March 1). Safe Beta Blockers in Patients with Reactive Airway Disease. American Academy of Family Physicians. https://www.aafp.org/pubs/afp/issues/2003/0301/p1112.html#:%7E:text=Beta%20blockers%20are%20widely%20used,their%20potential%20for%20causing%20bronchospasm.
Sahoo, S., Kariya, T., & Ishikawa, K. (2021). Targeted delivery of therapeutic agents to the heart. Nature reviews. Cardiology, 18(6), 389–399. https://doi.org/10.1038/s41569-020-00499-9
Sasano, T., Kikuchi, K., McDonald, A. D., Lai, S., & Donahue, J. K. (2007). Targeted high-efficiency, homogeneous myocardial gene transfer. Journal of molecular and cellular cardiology, 42(5), 954–961. https://doi.org/10.1016/j.yjmcc.2007.02.004
Schlimgen, R., Howard, J., Wooley, D., Thompson, M., Baden, L. R., Yang, O. O., Christiani, D. C., Mostoslavsky, G., Diamond, D. V., Duane, E. G., Byers, K., Winters, T., Gelfand, J. A., Fujimoto, G., Hudson, T. W., & Vyas, J. M. (2016). Risks Associated With Lentiviral Vector Exposures and Prevention Strategies. Journal of occupational and environmental medicine, 58(12), 1159–1166. https://doi.org/10.1097/JOM.0000000000000879
Singh S, McKintosh R. Adenosine. [Updated 2022 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519049/
Solomonov, I., Zehorai, E., Talmi-Frank, D., Wolf, S. G., Shainskaya, A., Zhuravlev, A., Kartvelishvily, E., Visse, R., Levin, Y., Kampf, N., Jaitin, D. A., David, E., Amit, I., Nagase, H., & Sagi, I. (2016). Distinct biological events generated by ECM proteolysis by two homologous collagenases. Proceedings of the National Academy of Sciences of the United States of America, 113(39), 10884–10889. https://doi.org/10.1073/pnas.1519676113
Sreenivas, S. (2022, April 14). Potassium channel blockers for MS: What to know. WebMD. Retrieved August 27, 2022, from https://www.webmd.com/multiple-sclerosis/potassium-channel-blockers-ms#:~:text=If%20you%20have%20moderate%20to,you're%2050%20or%20older.
Stanford Health Care (SHC). Types. Stanford Medical Center. (2017, September 11). Retrieved August 27, 2022, from https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/long-qt-syndrome/types.html
Starek, Z., Lehar, F., Jez, J., Wolf, J., & Novák, M. (2015). Hybrid therapy in the management of atrial fibrillation. Current cardiology reviews, 11(2), 167–179. https://doi.org/10.2174/1573403x10666140713172231
Strauss, J. H., & Strauss, E. G. (2008). Viruses and human disease. Elsevier / Academic Press.
Thomas, J. (2020, March 16). Facts and statistics about atrial fibrillation. Healthline. Retrieved August 27, 2022, from https://www.healthline.com/health/living-with-atrial-fibrillation/facts-statistics-infographic#Complications
Thormar H. (2013). The origin of lentivirus research: Maedi-visna virus. Current HIV research, 11(1), 2–9.
Tilemann, L., Ishikawa, K., Weber, T., & Hajjar, R. J. (2012). Gene therapy for heart failure. Circulation Research, 110(5), 777–793. https://doi.org/10.1161/circresaha.111.252981
Tornabene, P., & Trapani, I. (2020). Can adeno-associated viral vectors deliver effectively large genes? Human Gene Therapy, 31(1-2), 47–56. https://doi.org/10.1089/hum.2019.220
Trapani. (2019). Adeno-associated viral vectors as a tool for large gene delivery to the retina. Genes, 10(4), 287. https://doi.org/10.3390/genes10040287
U.S. Department of Health and Human Services (HHS). (2022). Atrial fibrillation and stroke. National Institute of Neurological Disorders and Stroke. Retrieved August 27, 2022, from https://www.ninds.nih.gov/health-information/disorders/atrial-fibrillation-and-stroke
Vishnevskii, A., & Tsukerman, B. (1961). Atrial defibrillation in 20 patients with mitral valve disease. J USSR Acad Med Sci, 8, 32-35.
Weinberg, M. S., & Morris, K. V. (2016). Transcriptional gene silencing in humans. Nucleic acids research, 44(14), 6505–6517. https://doi.org/10.1093/nar/gkw139
Wikimedia Foundation. (2021, December 7). RNA-directed DNA methylation. Wikipedia. Retrieved August 27, 2022, from https://en.wikipedia.org/wiki/RNA-directed_DNA_methylation#Potential_biotechnology_applications
Wikimedia Foundation. (2022, June 12). Wallace P. Rowe. Wikipedia. Retrieved August 27, 2022, from https://en.wikipedia.org/wiki/Wallace_P._Rowe
Wold, W. S., & Toth, K. (2013). Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Current gene therapy, 13(6), 421–433. https://doi.org/10.2174/1566523213666131125095046
Wu, S. S., Li, Q. C., Yin, C. Q., Xue, W., & Song, C. Q. (2020). Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases. Theranostics, 10(10), 4374–4382. https://doi.org/10.7150/thno.43360
Yan, Z., Zak, R., Zhang, Y., & Engelhardt, J. F. (2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. Journal of virology, 79(1), 364–379. https://doi.org/10.1128/JVI.79.1.364-379.2005
Zhang, J., Juhl, C.R., Hylten-Cavallius, L. et al. Gain-of-function mutation in the voltage-gated potassium channel gene KCNQ1 and glucose-stimulated hypoinsulinemia - case report. BMC Endocr Disord 20, 38 (2020). https://doi.org/10.1186/s12902-020-0513-x
Zhao, Y., & Huang, L. (2014). Lipid nanoparticles for gene delivery. Advances in genetics, 88, 13–36. https://doi.org/10.1016/B978-0-12-800148-6.00002-X
Published
How to Cite
Issue
Section
Copyright (c) 2022 Luke Sequeira
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.